A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Phase 3 Active not recruiting 371 enrolled Priovant Therapeutics, Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).

Timeline

Start: 2024-09-11
Primary completion: 2026-09-11
Completion: 2028-02-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Brepocitinib	Small molecule	—	Oral

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Summary

Timeline

Drugs

Indications